A Liberal Critique of Science

Governing Science and Technology in a Democracy. Malcolm L. Goggin, ed. University of Tennessee Press, Knoxville, 1986. 314 pp. $34.95. In the last decade or two, a coherent "radical critique" of science has taken shape in Europe and the United States. The critique attacks the notion that science can be significantly "value-free," arguing instead that at its heart, all science has been shaped in the interest of dominant economic and political sectors. Having recognized this, it becomes incumben

Written byEric Holtzman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

This book can be characterized as a "liberal" counterpart of the critique. The authors share the radicals' insistence that even at its most abstract, science is colored by context. They also share the distaste for some of the directions and effects of science and technology Like the radicals, most of the contributors to the book are alarmed by the increased penetration of corporate interests and the military into universities and by the inadequacies of existing mechanisms for ensuring the congruence of scientific effort with long-term social needs. The book's solutions, however, are more comfortable and conventional than the radicals': pluralism, public participation, open communication, accountability to democratic institutions and responsive systems for planning and regulation.

The group of political scientists, philosophers, lawyers, and one or two natural scientists assembled by Malcolm Goggin—of the Center for Public Policy at the University of Houston-University Park—met several times to discuss their chapters and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies